Justera Announces 2023 AGM Results
Toronto, Ontario--(Newsfile Corp. - December 7, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")...
Day: December 7, 2023
Stirling Introduces Its New Pure CBD Gummies, Solidifying Its Reputation as the Maker of the Best CBD Gummies
Stirling's Newest CBD Gummies Are Pure, Proven, and Tested by Customers and Doctors Across the U.S.SANTA CRUZ, CA / ACCESSWIRE...
Stirling Introduces Its New Pure CBD Gummies, Solidifying Its Reputation as the Maker of the Best CBD Gummies
Stirling's Newest CBD Gummies Are Pure, Proven, and Tested by Customers and Doctors Across the U.S.SANTA CRUZ, CA / ACCESSWIRE...
Olleyes Secures ANVISA Regulatory Approval for VisuALL VRP Platform in Brazil, Further Expanding Sales in Latin America
Regulatory approval brings latest tech to Latin America. Olleyes' VR testing platform increases access to care and increases office efficiency...
Kymera Therapeutics Announces First Patient Dosed in Phase 2 Atopic Dermatitis Clinical Trial of KT-474 (SAR444656), a First-in-Class, Investigational IRAK4 Degrader, Generating a $15 Million Payment from Sanofi
Atopic Dermatitis (AD) trial is the second KT-474 Phase 2 clinical trial to begin enrolling patients this quarter following trial...
Health-ISAC Announces Board Change
Health Information Sharing and Analysis Center (Health-ISAC) Thanks Departing Board Member and Welcomes New Board Member From GermanyORMOND BEACH, FL...
PDO Max and Rohrer Aesthetics Team Up to Offer PDO AfterGlo, the First Polydioxanone (PDO) Topical Serum Skin Booster
"Liquid PDO Threads" suspended in hyaluronic acid in combination with energy-based devices offer superior results. MAX-imize hydration, elasticity, texture, and...
MASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family Company
To register for the webinar, click hereSAN FRANCISCO, CA / ACCESSWIRE / December 7, 2023 / Napo Pharmaceuticals (Napo), a...
Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas With Dexcom G7 CGM System
Beginning Dec. 18, iLet users will have the option of using a Dexcom G7 CGM System.CONCORD, MA / ACCESSWIRE /...
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to...
Compass Pathways appoints Teri Loxam as Chief Financial Officer
LONDON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient...
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
Monaghan Medical Corporation Demonstrates Commitment to Plattsburgh Community With $100,000 Donation for New YMCA
Monaghan Medical Corporation Partners with Plattsburgh Community: $100,000 Donation Sparks Vitality in New YMCA Project with Doubling Effect through Anonymous...
MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial
MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial MC2-25 CKD is a first-in-class drug...
AlzeCure Presents at Redeye Investor Forum in Göteborg on December 14
STOCKHOLM, SE / ACCESSWIRE / December 07, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
First Patient Dosed in Spago Nanomedical’s Clinical Phase I/IIa Study within the Tumorad(R) Program
LUND, SE / ACCESSWIRE / December 07, 2023 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that the...